Εμφανίζονται 1 - 2 Αποτελέσματα από 2 για την αναζήτηση '"Феруза Одилжоновна Мирджамалова"', χρόνος αναζήτησης: 0,39δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal

    Πηγή: HIV Infection and Immunosuppressive Disorders; Том 7, № 1 (2015); 45-51 ; ВИЧ-инфекция и иммуносупрессии; Том 7, № 1 (2015); 45-51 ; 2077-9828 ; 10.22328/2077-9828-2015-7-1

    Περιγραφή αρχείου: application/pdf

    Relation: https://hiv.bmoc-spb.ru/jour/article/view/69/70; Li Y., Svehla K., Louder M.K. Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals // J. Virol.,- Jan. 2009. - Vol. 83. - Р. 1045-1059.; Liao H., Lynch R., Zhou T., Gao F., Alam S.M., Boyd S.D., Fire A.Z., Roskin K.M., Schramm C.A., Zhang Z. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus // Nature. - Apr. 2013. - Р. 469-476.; Mikell I., Sather D.N., Kalams S.A., Altfeld M., Alter G., Stamatatos L. Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1 // PLoS Pathog. - Jan. 2011. - Vol. 7. - Р. 1-15.; Walker L.M., Phogat S.K., Chan-Hui P.Y. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target // Science. - Oct. 2009. - Vol. 326. - Р. 285-288.; Walker L.M., Huber M., Doores K.J. Broad neutralization coverage of HIV by multiple highly potent antibodies // Nature. - Sept. 2011. - Vol. 477. - Р. 466-470.; Abraham R.J., Abrahams F., Tongo M. Refined Identification of Neutralization-Resistant HIV-1 CRF02_AG Viruses // J. of Virol. - July 2012. - Vol. 86. - Р. 7699-7703.; Andrabi R., Williams C., Wangb X.-H. Cross-neutralizing activity of human anti-V3monoclonal antibodies derived from non-B clade HIV-1 infected individuals // J. of Virol. - May 2013. - Vol. 439. - P. 81-88.; Doria-Rose N.A., Klein R.M., Manion M.M. Frequency and Phenotype of Human Immunodeficiency Virus Envelope-Specific B Cells from Patients with Broadly Cross-Neutralizing Antibodies // J.Virol.,- Jan. 2009. - Vol. 83. - Р. 188-199.; Melissa D. Simek M.D., Rida W., Priddy F.H., Pham P., Carrow E., Läufer D.S., Lehrman J.K. Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm // J. Virol. - July 2009. - Vol. 83. - Р. 7337-7348.; Seaman M. S., Janes H., Hawkins N. Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies // J. Virol. - Feb. 2010. - Vol. 84. - Р. 1439-1452.; Chun T.W., Mirray D., Justement J.S. Blazkova J., Claire W. Hallahan D. Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir // PNAS - July 2014. - Vol. 111. - Р. 1073-1079.; Gils M.J., Sanders R.W. In vivo protection by broadly neutralizing HIV antibodies // Trends in Microbiology, Oct. 2014. - Vol. 22. - P. 550-551.; Chaillon A., Braibant M., Hue S. et al. Human Immunodeficiency Virus Type-1 (HIV-1) Continues to Evolve in Presence of Broadly Neutralizing Antibodies More than Ten Years after Infection // PLoS. - Aug. 2012. - Vol. 7. - P. 1-13.; Гашникова Н.М., Сафронов П.Ф., Никонорова Ю.В., Унагаева Н.В., Лаптева Т.А., Богачев В.В. Изучение свойств изолятов CRF02_AG ВИЧ-1, циркулирующих на территории Новосибирской области // Журн. микробиологии, эпидемиологии и иммунобиологии. - 2011. - № 3. - С. 38-43.; Baryshev P.B., Bogachev V.V., Gashnikova N.M. Genetic characterization of HIV-1 strains recombinant form AG circulating in Siberia, Russia // Archives of Virol. - Aug. 2012. - Vol. 157. - P. 2335-2341.; Peeters M., Liegeois F., Torimiro N., Bourgeois A., Mpoudi E. Characterization of a Highly Replicative Intergroup M/O Human Immunodeficiency Virus Type 1 Recombinant Isolated from a Cameroonian Patient // J. of Virol. - Sept. 1999. - Vol. 73. - Р. 7368-7375.

  2. 2

    Πηγή: HIV Infection and Immunosuppressive Disorders ; ВИЧ-инфекция и иммуносупрессии